Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Evidence-based management for preeclampsia.

Peter von Dadelszen1, Jennifer Menzies, Sarah Gilgoff

  • 1Department of Obstetrics and Gynaecology, University of British Columbia and British Columbia Reproductive Care Program, Provincial Health Services Authority, Vancouver, BC, Canada. pvd@cw.bc.ca

Frontiers in Bioscience : a Journal and Virtual Library
|May 9, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Walking Together: Advancing Culturally Grounded Diabetes Care in Indigenous Communities.

Healthcare management forum·2026
Same author

Nuts'a'maat shqwaluwun - Knitting ways of life with Indigenous research principles to examine preterm birth in Quw'utsun.

Canadian journal of public health = Revue canadienne de sante publique·2025
Same author

Sustaining and Inspiring the Capacity of the Nursing Profession: The Case for Transformative Practice Education Models.

Nursing leadership (Toronto, Ont.)·2023
Same author

Guideline No. 432a: Cervical Ripening and Induction of Labour - General Information.

Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC·2023
Same author

Directive clinique n<sup>o</sup> 432a : Maturation cervicale et déclenchement artificiel du travail - Information générale.

Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC·2023
Same author

Guideline No. 432b: Cervical Ripening.

Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC·2023
Same journal

The CD44 protein family: roles in embryogenesis and tumor progression.

Frontiers in bioscience : a journal and virtual library·2017
Same journal

Four varieties of voltage-gated proton channels.

Frontiers in bioscience : a journal and virtual library·2017
Same journal

Lurie's tubercle-count method to test TB vaccine efficacy in rabbits.

Frontiers in bioscience : a journal and virtual library·2017
Same journal

Optical spectroscopy of breast biopsies and human breast cancer xenografts in nude mice.

Frontiers in bioscience : a journal and virtual library·2017
Same journal

The colostrum-deprived, artificially-reared, neonatal pig as a model animal for studying rotavirus gastroenteritis.

Frontiers in bioscience : a journal and virtual library·2017
Same journal

Action of polypeptide growth factors in colon cancer; development of new therapeutic approaches.

Frontiers in bioscience : a journal and virtual library·2017
See all related articles

Preeclampsia is a systemic disorder affecting multiple organs. Comprehensive maternal and fetal surveillance, timely antihypertensive treatment, and magnesium sulfate for eclampsia are crucial for managing this condition and preventing long-term cardiovascular risks.

Area of Science:

  • Obstetrics and Gynecology
  • Maternal-Fetal Medicine
  • Nephrology

Background:

  • Preeclampsia is a complex systemic disorder with variable clinical presentations.
  • It affects multiple maternal organ systems and the fetus, necessitating a comprehensive management approach.

Purpose of the Study:

  • To review the systemic nature of preeclampsia and provide recommendations for evaluating and managing associated organ dysfunction.
  • To outline current guidelines for antihypertensive treatment, eclampsia prophylaxis, and fluid management.
  • To highlight the long-term cardiovascular risks associated with early-onset or severe preeclampsia.

Main Methods:

  • Systematic review of current literature and clinical guidelines on preeclampsia management.
  • Analysis of diagnostic criteria and therapeutic interventions for maternal organ dysfunction.

Related Experiment Videos

  • Evaluation of evidence for expectant management in remote-term preeclampsia and long-term cardiovascular risk prediction.

    • Main Results:

    • Preeclampsia affects multiple organ systems, requiring thorough maternal and fetal surveillance.
    • Expectant management for preeclampsia remote from term (<34 weeks) improves perinatal outcomes but demands rigorous maternal monitoring.
    • Specific antihypertensive medications (Methyldopa, Labetalol, Nifedipine) are recommended, with certain drugs to avoid (ACE inhibitors, ARBs, atenolol).
    • Magnesium sulfate (MgSO4) is indicated for eclampsia prophylaxis and treatment.
    • Fluid management guidelines emphasize limiting intake and tolerating low urine output.
    • Early-onset or severe preeclampsia is linked to future cardiovascular morbidity and mortality.

    Conclusions:

    • Preeclampsia requires a holistic management strategy addressing systemic involvement and potential organ dysfunction.
    • Timely initiation of antihypertensive therapy and appropriate use of magnesium sulfate are critical for maternal and fetal well-being.
    • Women with early-onset or severe preeclampsia should be considered for long-term cardiovascular risk screening and intervention.